The latest issue of Rowan Research News highlights Rowan University research on bone cancer, advanced materials, climate ...

Diffuse gastric cancer (DGC) is an aggressive gastric cancer subtype with a poor prognosis. The RHOA Y42C mutation is recurrent in DGC, but its independent oncogenic role is unclear. Next-Generation ...

“The data we're seeing on GLP-1s and cancer risk reduction is exciting, and medical oncologists are watching it closely,” says Dr. Rahul Gosain, an oncologist and co-host of The Oncology Brothers.

Why is it that some people respond well to the same medication while others do not?Is there any support we can provide from ...

Newswise — SAN DIEGO, APRIL 14, 2026 ― Researchers from The University of Texas MD Anderson Cancer Center will present breakthrough studies at the American Association for Cancer Research (AACR) ...

The Alliance for Clinical Trials in Oncology is a national leader in advancing cancer research, uniting more than 26,000 cancer specialists at 112 main institutions and 1,400 affiliates across the U.S ...

Cancer survival rates are improving thanks to faster, more effective treatments. Several major breakthroughs could transform cancer care, including mRNA cancer vaccines, immunotherapy, and gene ...

On the 18th, the Korean Cancer Society (Chairman La Sun-young, Professor of Yonsei University) held a press conference at Lotte Hotel in Sogong-dong, Seoul to commemorate the publication of the 「Korea ...